Year Established :
2013
Total Assets(USD) :
500,000 to 99,999,999
Total Number of Staff :
50-100
Main Competitive Advantages :
Brand Name,Experienced R&D Staff,Delivery Term,Production Capacity,Contract Manufacturing (CRO,CMO),Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages :
R&D Strength: With strong R&D capabilities, Tongjun Pharmaceutical has obtained multiple invention patents, including a patent for the synthesis process innovation of copper peptides, which reduces the use of protective bases, simplifies production steps, and improves yield while reducing waste discharge.
Production Bases: The company has production bases in Guangzhou and Shaoguan, covering various fields such as pharmaceuticals, pharmaceutical intermediates, specialty chemicals, and daily chemical raw materials.
Corporate Honors: Tongjun Pharmaceutical has received several qualifications and honors, including "Guangzhou City's Science and Technology Innovation Little Giant Enterprise" and "National High-tech Enterprise."
Product Line: The product line covers four major categories: anti-aging and wrinkle reduction, whitening and antioxidant, anti-irritation and soothing, and antiseptic and dandruff removal, including peptide raw materials and other effective beauty ingredients, which are synthesized automatically using the company's independently developed EMPHASES® peptide technology.
Market Influence: Tongjun Pharmaceutical's copper peptide products have won the title of "2023 Guangdong Province's Famous and High-quality High-tech Product" due to their high quality and environmental friendliness.
Corporate Values: The company adheres to the corporate values of "integrity, innovation, unity, and creating beauty," committed to providing high-quality products and services to customers.
Environmental Philosophy: Tongjun Pharmaceutical focuses on green development, providing cost-effective efficacy ingredients for the industry through process optimization and innovation, meeting energy-saving and emission reduction requirements, and suitable for industrial production.
Patents and Copyrights :
Patent Certificate 2022100809913-A compound containing trityl structure and its application
Patent Certificate 2013101829879-A method for synthesizing oseltamivir phosphate without azide
Patent Certificate 2015102060020-Synthesis process of key intermediate of tenofovir alafenamide hemifumarate
Patent Certificate 2015102064680-Synthesis process of 5-aryl-1H-pyrazolo[4,3-d]pyrimidine-7(6H)-one (sildenafil intermediate)
Patent Certificate 2018101560066-A thio compound and its application-certificate
Patent Certificate 2018101560 263-A method for preparing a key intermediate I of green card selin
Patent certificate 2018101561868-A new method for synthesizing 1,6-(p-amidinophenyl) hexane diether
Patent certificate 2018103915250-An aminodithiocarboxylate compound and its application
Patent certificate 2019102137514-A composition and its application
Patent certificate 2019104055491-A compound containing a fluorene ring structure and its application
Patent certificate 2019104088283-A compound containing a benzyl structure and its application
Patent certificate 2019104763620 - A compound containing a diphenylmethane structure and its application
Patent certificate 2021215563438 - Liquid phase polypeptide automatic synthesis device
Patent certificate 2023118141709-Genetically engineered bacteria producing ergothioneine and its application in the production of ergothioneine
Patent certificate 2023118142025-Genetically engineered bacteria and its application in the production of ergothioneine
Patent certificate-2024100706070-Polyetheramide, its preparation method and its application in hair damage repair
Patent certificate A compound containing a trityl structure and its application +2022100809913
Business Type :
Manufacturer
R&D Capacity :
OEM,Own Brand
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Range :
Semaglutide & Tizepatide Intermediates
Comestic Peptides
SNAC
One year of qualification
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
